SOUTH SAN FRANCISCO, Calif., April 26, 2017 /PRNewswire/ -- Biocompare, a Division of CompareNetworks, Inc. and the leading product information resource for the life sciences, has launched the seventh in an ongoing series of digital immersive platforms called Future Lab: Trends in Biopharmaceutical Analysis (http://www.biocompare.com/Future-Lab/Biopharmaceutical-Analysis/). This interactive content hub, sponsored by Agilent was created to share the latest advances, trends, and applications in the analysis of complex biotherapeutics. In this Future Lab, researchers will learn about the appropriate tools and techniques needed to characterize biologic products, the importance of post-translational modifications, and how to overcome challenges associated with characterization of mAbs and therapeutic proteins.
There has been a positive response to these content hubs; in 2016 Biocompare launched four other Future Labs. The first Future Lab focused on Protein Production. Sponsored by Bio-Rad this hub focused on content targeted to scientists that are involved in all aspects of this process, from basic research through therapeutic protein production. The second Future Lab was specific to Immunodetection. Sponsored by Bio-Techne the Immunodetection Future Lab featured information on various aspects of antibody based applications. The third Future Lab was on maintaining a cell culture facility sponsored by NuAire. The fourth Future Lab was on Flow Cytometry sponsored by Thermo. The fifth Future Lab was on Liquid Handling sponsored by Gilson. The most recent Future Lab was sponsored by Roche and focuses on Trends in Next-Gen Sequencing.
"We are really excited to have developed this platform to allow the 3 million scientists who visit Biocompare each year to be able to consume content in a much more engaging environment. This fully supports Biocompare's mission to educate scientists in the latest technology while providing the tool provider community a unique and novel way to engage with our audience," says Joan Boyce, VP & GM of Biocompare.
Future Lab brings together topical content and presents it in a focused and interactive environment to keep readers informed of the latest developments in research. The benefit of this is that as content gets added, users will be notified and come back over time to consume content. With all the available resources out there to users, it's the best way to push out content and see an immediate response.
"The creation of Future Lab is the next phase of growth and content development for Biocompare and we're excited about launching additional Future Labs in areas that are driving basic and translational research," says Mike Okimoto, Ph.D., Biocompare's co-founder and Chief Content Officer. "The next iteration of the platform will provide additional engagement opportunities and we look forward to rolling them out in the coming months."
Creating a community through content is what keeps users engaged and will in turn bring the scientific community closer.
Biocompare, a Division of CompareNetworks, Inc. is the leading resource for up-to-date product information, product reviews, and new technologies for life scientists. Biocompare combines in-depth knowledge of the life science products and new technologies with the power of the Internet to offer scientists the most dynamic, relevant, and innovative media-based marketplace for life science information. Produced by scientists, Biocompare's mission is to provide free, time saving services to life science researchers, allowing scientists to find and learn about the technologies that drive discovery. Biocompare continually strives to serve the life science community by providing new and improved online services that facilitate product discovery and technology education. For more information, please visit www.biocompare.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/biocompare-inc-launches-the-trends-in-biopharmaceutical-analysis-future-lab-300446340.html